2m 2m 2m 2m 2m 2m 2m
Gilead Sciences (GILD)
NASDAQ
$125.51+$0.64 (+0.51%)
Price as of Jun 23, 2026 12:36 PM EDT- $155.0BMarket Cap
- 20.65%1-Year Change
- Drug Manufacturers - GeneralIndustry
Gilead Sciences (GILD)
$125.51+$0.64 (+0.51%)
GILD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $124.87 | ||
Change | +$1.11 (+0.90%) | ||
Open | $124.30 | ||
High | $125.17 | ||
Low | $123.00 | ||
Previous Close | $123.76 | ||
Volume | 8,126,314 | ||
30-Day Average Volume | 9,104,997 | ||
1-Week Change | 0.46% | ||
1-Month Change | -6.45% | ||
1-Year Change | 20.65% | ||
3-Year Change | 76.44% | ||
5-Year Change | 123.52% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $56.3B | ||
Market Cap | $155.0B | ||
Enterprise Value | $169.6B | ||
Period: QTR TTM FY | |||
Revenue | $6.9B | ||
Net Income | $2.0B | ||
Free Cash Flow | $2.4B | ||
EBIT | $2.6B | ||
EBITDA | $2.7B | ||
Net Working Capital | $9.2B | ||
EPS | $1.61 | ||
Enterprise Value/EBITDA | 63 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 7 | ||
P/E | 78 | ||
PEG | -10 | ||
Price/Free Cash Flow | 64 | ||
Price/Operating Cash Flow | 61 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.63% | ||
Trailing Annual Dividend Yield | 2.58% | ||
Ex-Dividend Date | 06/15/2026 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 01/28/2013 | ||
Earnings & Revenue
Annual Dividend Yield